Nurix Therapeutics
NRIX
Nurix Therapeutics (NRIX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Needham | Maintained | Buy | $34.00 | Oct 13, 2026 |
| Baird | Maintained | Outperform | $36.00 from $33.00 | Oct 13, 2026 |
| Truist Securities | Maintained | Buy | $33.00 from $34.00 | Oct 13, 2026 |
| Oppenheimer | Maintained | Outperform | $32.00 from $28.00 | Oct 13, 2026 |
| RBC Capital | Maintained | Outperform | $35.00 from $36.00 | Oct 13, 2026 |
| RBC Capital | Maintained | Outperform | $36.00 from $33.00 | Aug 10, 2026 |
| Needham | Maintained | Buy | $34.00 | Aug 4, 2026 |
| Morgan Stanley | Maintained | Overweight | $38.00 from $36.00 | Jul 28, 2026 |
| UBS | Maintained | Buy | $31.00 from $23.00 | Jul 22, 2026 |
| Mizuho | Maintained | Outperform | $34.00 from $30.00 | Jul 13, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $34.00 from $32.00 | Jul 10, 2026 |
| Needham | Maintained | Buy | $34.00 | Jul 10, 2026 |
| BTIG | Maintained | Buy | $32.00 | Jul 10, 2026 |
| RBC Capital | Maintained | Outperform | $33.00 from $30.00 | Jul 10, 2026 |
| Stifel | Maintained | Buy | $40.00 from $34.00 | Jul 10, 2026 |
| Truist Securities | Maintained | Buy | $34.00 from $32.00 | Jul 10, 2026 |
| Baird | Maintained | Outperform | $33.00 from $26.00 | Jun 18, 2026 |
| Needham | Maintained | Buy | $34.00 | Jun 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $32.00 | Jun 10, 2026 |
| BTIG | Maintained | Buy | $32.00 from $30.00 | Jun 9, 2026 |
Frequently asked questions
What is the latest analyst rating on NRIX?
On Oct 13, 2026, Needham maintained Nurix Therapeutics at Buy with a price target of $34.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.